Acetylator genotype and Parkinson's disease (multiple letters) [13]

Lancet

Volumn 351, Issue 9096, 1998, Pages 141-142

  Paolini, M ^a   Nicholl, D J ^a   Bennett, P ^a   Bandmann, O ^a   Wood, N W ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; DNA; NEUROTOXIN; ARYLAMINE ACETYLTRANSFERASE;

ALLELE; DNA ADDUCT; DNA POLYMORPHISM; ENVIRONMENTAL EXPOSURE; GENE MUTATION; GENOTYPE; HUMAN; LETTER; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; ACETYLATION; ENZYMOLOGY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; METABOLISM; NOTE;

ACETYLATION; ARYLAMINE N-ACETYLTRANSFERASE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; PARKINSON DISEASE; POLYMORPHISM, GENETIC;

EID: 0032501603     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0140-6736(05)78117-4     Document Type: Letter

References (4)

1. O Bandmann J Vaughan P Holmans CD Marsden NW Wood Association of slow acetylator genotype for N-acetyltransferase 2 with familial Parkinson's disease Lancet 350 1997 1136 1139
2. O Bandmann CD Marsden NW Wood Genetic polymorphisms of three detoxification enzymes in familial and sporadic Parkinson's disease Neurology 48 1997 A182 A183
3. I Cascorbi N Drakoulis J Brockmoller A Maurer K Sperling I Roots Arylamine-acetyltransferase (Nat2) mutations and their allelic linkage in unrelated caucasian individuals—correlation with phenotypic activity Am J Hum Genet 57 1995 581 592
4. K Ray-Chaudhuri C Smith AC Gough Debrisoquine hydroxylase gene polymorphism in Parkinson's disease and amyotrophic lateral sclerosis J Neurol Neurosurg Psychiatry 58 1995 109